Archives of microbiology

Using the CRISPR/Cas system as a new treatment against bacteria resistant to many drugs

Updated

Abstract

CRISPR-Cas technology may specifically target resistance genes like tetM and ermB to reduce antimicrobial resistance in various bacteria.

  • Antimicrobial resistance (AMR) is a significant threat to global health and economic stability.
  • CRISPR antimicrobial strategies enable targeted elimination of resistance genes while preserving beneficial microbes.
  • Recent studies indicate that CRISPR affects multiple bacterial species, including Enterococcus faecium and Staphylococcus aureus.
  • CRISPR-Cas9 has been shown to decrease resistance by focusing on specific genes related to AMR.
  • Challenges remain in improving delivery systems, ensuring target specificity, and addressing biosafety concerns in clinical applications.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free